Dare Bioscience, Inc. (DARE)


Stock Price Forecast

April 17, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Dare Bioscience, Inc. chart...

About the Company

We do not have any company description for Dare Bioscience, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

26

Exchange

Nasdaq

$1M

Total Revenue

26

Employees

$28M

Market Capitalization

-0.72

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $DARE News

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript

17d ago, source: InvestingChannel on MSN

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript March 28, 2024 Daré Bioscience, Inc. beats earnings ...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.12%

on MSN ago, source:

U.S. stocks were lower after the close on Wednesday, as losses in the Technology, Industrials and Consumer Services sectors ...

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

22d ago, source: Business Insider

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update. “We are ...

Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript

21d ago, source: Seeking Alpha

Welcome to the conference call hosted by Daré Bioscience to review the company’s Fourth Quarter Financial Results and to provide a General Business Update. This call is being recorded.

Daré Bioscience, Inc. (DARE)

3d ago, source: Yahoo Finance

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected ...

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

22d ago, source: Nasdaq

SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31 ...

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript

18d ago, source: Insider Monkey

Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12. DARE isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

Dare Bioscience Inc

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

22d ago, source: Yahoo Finance

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ...

Q4 2023 Dare Bioscience Inc Earnings Call

21d ago, source: Yahoo Finance

Sabrina Martucci Johnson; President and CEO; Dare Bioscience, Inc. MarDee Haring-Layton; Chief Accounting Officer; Dare Bioscience, Inc. Douglas Tsao; Analyst; H.C ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...